Recent Finacing
Recent Raise
SQZ Biotechnologies uses its Cell Squeeze microfluidic platform to deliver biological cargo into cells, producing engineered APCs and cell therapies for oncology, autoimmunity and neuronal replacement with point-of-care manufacturing.